About
PMC's Annual Award for Leadership in Personalized Medicine

Ellen Sigal, Ph.D., Founder, Chairperson, Friends of Cancer Research, accepts the 14th Annual Award for Leadership in Personalized Medicine from Steven D. Averbuch, M.D., formerly Vice President and Head of Precision Medicine at Bristol-Myers Squibb.
Nomination Period to Re-Open in March of 2019
The nomination period for the 15th Annual Award for Leadership in Personalized Medicine will open in March of 2019.
About the Award
The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.
Previous award recipients include:
- Ellen V. Sigal, Ph.D. (2018)
Chairperson, Founder
Friends of Cancer Research
- Jay T. Flatley (2017)
Executive Chairman
Illumina
- Raju Kucherlapati, Ph.D. (2016)
Paul C. Cabot Professor of Genetics
Harvard Medical School
- Francis S. Collins, M.D., Ph.D. (2015)
Director
National Institutes of Health (NIH)
- Mark Levin (2014)
Co-founder, Partner
Third Rock Ventures
- Kathy Giusti (2013)
Founder, Chief Executive Officer
Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
- Randal W. Scott, Ph.D. (2012)
Co-Founder
InVitae Corporation - Leroy Hood, Ph.D., M.D. (2011)
President
Institute for Systems Biology - William S. Dalton, Ph.D., M.D. (2010)
CEO
M2GEN
Director
DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center - Brook Byers (2009)
Managing Partner
Kleiner Perkins Caufield & Byers (KPCB) - Michael O. Leavitt (2008)
Founder and Chairman
Leavitt Partners - Ralph Snyderman, M.D. (2007)
Chancellor Emeritus
Duke University
Founder and Chairman
Proventys, Inc.
- Elizabeth G. Nabel, M.D. (2006)
President
Brigham and Women's Health Care - Janet Woodcock, M.D. (2005)
Director
FDA Center for Drug Evaluation and Research